Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
2020; Elsevier BV; Volume: 107; Issue: 4 Linguagem: Inglês
10.1016/j.ijrobp.2020.04.016
ISSN1879-355X
AutoresDavid Thomson, David A. Palma, Matthias Gückenberger, Panagiotis Balermpas, Jonathan J. Beitler, Pierre Blanchard, David M. Brizel, W. Budach, Jimmy J. Caudell, June Corry, Renzo Corvò, Mererid Evans, Adam S. Garden, J. Giralt, Vincent Grégoire, Paul M. Harari, Kevin J. Harrington, Ying J. Hitchcock, Jørgen Johansen, J.H.A.M. Kaanders, Shlomo A. Koyfman, Johannes A. Langendijk, Quynh‐Thu Le, Nancy Y. Lee, Danielle N. Margalit, Michelle Mierzwa, Sandro Porceddu, Yoke Lim Soong, Ying Sun, Juliette Thariat, John Waldron, Sue S. Yom,
Tópico(s)Radiation Dose and Imaging
ResumoBecause of the unprecedented disruption of health care services caused by the COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) identified an urgent need to issue practice recommendations for radiation oncologists treating head and neck cancer (HNC) in a time of limited resources and heightened risk for patients and staff.
Referência(s)